Results 31 to 40 of about 3,449 (222)
Health Science Reports, 2022 Background and Aims Platelet transfusion refractoriness is well aware to be associated with poor clinical outcomes. Patients with the alloantibody causing refractoriness required cross‐matched compatible products to improve the platelet number.
Thunnakhon Sinwatcharaphirom +2 more
doaj +1 more source
Transfusion effect of 0.5-dose of apheresis platelet in pediatric patients
Zhongguo shuxue zazhi, 2023 Objective To investigate the transfusion effect of 0.5-dose of apheresis platelet in pediatric patients. Methods A total of 195 children who underwent 0.5-dose platelet transfusion from August 2021 to June 2022 were enrolled, and the platelet count ...
Lijuan QIU +3 more
doaj +1 more source
Donor demographic and laboratory predictors of single donor platelet yield [PDF]
, 2013 Background: Platelet transfusions are essential to prevent morbidity and mortality in patients who are severely thrombocytopenic and are at risk of spontaneous bleeding.
A. Yashovardhan +5 more
core +1 more source
Asian Journal of Transfusion Science, 2015 Platelet transfusions have contributed to the revolutionary modern treatment of hypoproliferative thrombocytopenia. Despite the long-term application of platelet transfusion in therapeutics, all aspects of their optimal use (i.e., in cases of ABO and/or ...
Serena Valsami +4 more
doaj +1 more source
Ultrasonography-guided central venous catheterisation in haematological patients with severe thrombocytopenia [PDF]
, 2013 BACKGROUND: Cannulation of the internal jugular vein (CVC) is a blind surface landmark-guided technique that could be potentially dangerous in patients with very low platelet counts.
CAJOZZO, Massimo +10 more
core +1 more source
Efficacy of apheresis platelet transfusion in 310 patients with haematological diseases
Zhongguo shuxue zazhi, 2023 Objective To observe the effect of platelet transfusion in inpatients with haematological diseases, analyze the possible causes of platelet transfusion refractoriness (PTR), in order to further improve the efficacy of platelet transfusion.
Shisong YOU +5 more
doaj +1 more source
Platelets in liver disease, cancer and regeneration [PDF]
, 2017 Although viral hepatitis treatments have evolved over the years, the resultant liver cirrhosis still does not completely heal. Platelets contain proteins required for hemostasis, as well as many growth factors required for organ development, tissue ...
Kurokawa Tomohiro +2 more
core +2 more sources
Asian Journal of Transfusion Science, 2015 Background: This study was designed to determine the prevalence and assess the risk factors responsible for platelet transfusion refractoriness in hemato-oncological patients. Materials and Methods: The study included 30 patients.
Vijay Kumawat +3 more
doaj +1 more source
New approaches to preparation and storage of platelets [PDF]
, 2012 During the last century, transfusion of blood components has become a prerequisite for treatment in many clinical settings. The availability of plastic bags and methods for centrifugation and separation of blood cells, has enabled processing of whole ...
Larsson, Stella
core +1 more source
Zhongguo shuxue zazhi[Objective] To evaluate the performance of platelet efficacy score (PEscore) in predicting platelet transfusion efficacy in hematological patients. [Methods] A total of 485 patients with hematological diseases, including 298 males (62.09±15.45 years) and
LI Jun +4 more
doaj +1 more source